Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 4 boards, counting each seat separately. Longest: Illumina Inc., 3 years.
Illumina Inc.
Director
Pfizer Inc.
Director
Tempus AI Inc.
Director
UnitedHealth Group Incorporated
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Illumina Inc. May 21, 202696.8%
-
Tempus AI Inc. May 21, 202695.6%
-
Pfizer Inc. April 23, 202696.3%
-
Illumina Inc. May 21, 202598.8%
-
Tempus AI Inc. May 20, 202595.3%
-
Pfizer Inc. April 24, 202598.1%
-
Illumina Inc. May 16, 202494.7%
-
Pfizer Inc. April 25, 202498.7%
-
Illumina Inc. May 25, 202395.0%
-
Pfizer Inc. April 27, 202399.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | UnitedHealth Group Incorporated | Grant or award | +5 | — | — |
| Jul 1, 2026 | UnitedHealth Group Incorporated | Grant or award | +210 | — | — |
| Jun 23, 2026 | UnitedHealth Group Incorporated | Grant or award | +3 | — | — |
| May 21, 2026 | Tempus AI Inc. | Grant or award | +5,913 | — | — |
| May 21, 2026 | Illumina Inc. | Grant or award | +2,072 | $144.83 | $300,088 |
| Apr 1, 2026 | UnitedHealth Group Incorporated | Grant or award | +320 | — | — |
| Mar 17, 2026 | UnitedHealth Group Incorporated | Grant or award | +1 | — | — |
| Feb 9, 2026 | Illumina Inc. | Open-market purchase | +200 | $117.81 | $23,562 |
| Jan 2, 2026 | UnitedHealth Group Incorporated | Grant or award | +125 | — | — |
| Nov 3, 2025 | Illumina Inc. | Open-market purchase | +500 | $122.13 | $61,065 |
| May 21, 2025 | Illumina Inc. | Grant or award | +3,780 | — | — |
| May 20, 2025 | Tempus AI Inc. | Grant or award | +1,997 | — | — |
| Apr 1, 2025 | Tempus AI Inc. | Open-market sale | −5,006 | $46.07 | $230,626 |
| Apr 1, 2025 | Tempus AI Inc. | Open-market sale | −16,273 | $47.10 | $766,458 |
| Apr 1, 2025 | Tempus AI Inc. | Open-market sale | −4,000 | $48.13 | $192,520 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.